ConductScience.org, home

Paper62582

Labetalol in long-term treatment of hypertension.

Prichard BN and 1 other. Br J Clin Pharmacol, 1976. Cited by 92 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Labetalol in long-term treatment of hypertension. Papers, record 62582. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62582

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Labetalol in long-term treatment of hypertension.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
6.22
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prichard BNB N
2Boakes AJA J

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Adrenergic Agents
Adrenergic beta-Antagonists
Adult
Aged
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Evaluation
Female
Humans
Male
Methyldopa
Middle Aged
Posture

Source PubMed

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
7,374,093Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.Klin Wochenschr1980https://conductscience.org/library/papers/7374093PubMed
7,371,699Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7371699PubMed
7,093,102Labetalol steady-state pharmacokinetics in hypertensive patients.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093102PubMed
7,093,092Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093092PubMed
7,075,640Comparison of labetalol and clonidine in hypertension.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7075640PubMed
7,042,373Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7042373PubMed
6,419,809"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6419809PubMed
6,310,204Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.Klin Wochenschr1983https://conductscience.org/library/papers/6310204PubMed
6,151,891Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs1984https://conductscience.org/library/papers/6151891PubMed
6,124,264Labetalol in essential hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124264PubMed
3,908,121Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3908121PubMed
3,899,671A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3899671PubMed
3,881,105Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.Br Heart J1985https://conductscience.org/library/papers/3881105PubMed
3,530,297The management of hypertension.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3530297PubMed
2,908,732Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/2908732PubMed
1,350,483Clinical experience with dual-acting drugs in hypertension.Clin Investig1992https://conductscience.org/library/papers/1350483PubMed
760,749Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/760749PubMed
760,748Rate of onset of hypotensive effect of oral labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/760748PubMed
526,408Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526408PubMed
526,398Long-term treatment of hypertension with labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526398PubMed

See all 29 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/62582

GET https://conductscience.org/api/papers/v1/62582/cited_by?page=2